Does VOXELOTOR Cause Therapy cessation? 1,038 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,038 reports of Therapy cessation have been filed in association with VOXELOTOR (OXBRYTA). This represents 4.7% of all adverse event reports for VOXELOTOR.
1,038
Reports of Therapy cessation with VOXELOTOR
4.7%
of all VOXELOTOR reports
5
Deaths
309
Hospitalizations
How Dangerous Is Therapy cessation From VOXELOTOR?
Of the 1,038 reports, 5 (0.5%) resulted in death, 309 (29.8%) required hospitalization, and 1 (0.1%) were considered life-threatening.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VOXELOTOR. However, 1,038 reports have been filed with the FAERS database.
What Other Side Effects Does VOXELOTOR Cause?
Sickle cell anaemia with crisis (11,023)
Product dose omission issue (5,122)
Diarrhoea (3,173)
Off label use (2,364)
Nausea (2,003)
Headache (1,683)
Abdominal pain upper (1,165)
Pain (1,059)
Fatigue (1,004)
Abdominal discomfort (961)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
SECUKINUMAB (620)
Which VOXELOTOR Alternatives Have Lower Therapy cessation Risk?
VOXELOTOR vs VUTRISIRAN
VOXELOTOR vs VX-770
VOXELOTOR vs VX-950
VOXELOTOR vs VYVANSE
VOXELOTOR vs WARFARIN